KOD
Kodiak Sciences Inc. · Healthcare · Market cap $6.2B
Insiders bought $178.6M net in the last 90 days ·1 seller, 1 buyer· 1 of 1 sale under Rule 10b5-1 plans· latest Form 4 filed Nov 6, 2026
Insider Buying
$241.3M
reported purchases (SEC code P)
Insider Selling
$4.9M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Nov 6, 2026
BAKER BROS. ADVISORS LP
Kodiak Sciences Inc. (KOD) has 12 SEC Form 4 filings (111 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Nov 6, 2026.
Inside the rolling window, 2 insiders at Kodiak Sciences Inc. reported 5 open-market purchases totaling $241.3M and 3 open-market sales totaling $4.9M. The most active filer is Director, 10% Owner BAKER BROS. ADVISORS LP with 5 filings. Insiders have net bought $177.6M over the trailing 6 months. The largest single insider purchase in this window was $154.1M by Director, 10% Owner BAKER BROS. ADVISORS LP on Sep 28, 2026. The most recent open-market filing is a purchase of 160,658 shares by Director, 10% Owner BAKER BROS. ADVISORS LP, dated Nov 4, 2026, worth $15.8M.
- Industry:Biotechnology
- CEO:Victor Perlroth
- Employees:141
- HQ:Palo Alto, CA, US
- IPO:2018-10-04
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director, 10% Owner | Purchase | 160,658 | $15.8M | Nov 6 | -1.4% | SEC ↗ | |
| Director, 10% Owner | Purchase | 86,432 | $8.5M | Nov 6 | -1.4% | SEC ↗ | |
BORGESON JOHN A.First in 5 months | Chief Financial Officer | Sale | 30,000 | $2.7M | Oct 23 | +11.7% | SEC ↗ |
| Director, 10% Owner | Purchase | 1,908,029 | $154.1M | Sep 30 | — | SEC ↗ | |
| Director, 10% Owner | Purchase | 33,726 | $2.9M | Sep 30 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 30,000 | $1.0M | Jun 5 | — | SEC ↗ | |
BORGESON JOHN A.First filing | Chief Financial Officer | Sale | 30,000 | $1.2M | Apr 2 | — | SEC ↗ |
| Director, 10% Owner | Purchase | 2,608,696 | $60.0M | Dec 19 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading KOD 2 all-time
- RRep. Chris JacobsOther$1,001 - $15,0002022-11-08
- RRep. Chris JacobsPurchase$1,001 - $15,0002022-07-18
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does KOD have?
Kodiak Sciences Inc. (KOD) has 12 SEC Form 4 filings (111 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Nov 6, 2026.
When was the most recent SEC Form 4 filing for KOD?
The most recent Form 4 filing for KOD on Tracefour is dated Nov 6, 2026.
Who is the most active insider at KOD?
The most active SEC Form 4 filer at KOD in the rolling window is Director, 10% Owner BAKER BROS. ADVISORS LP, with 5 filings.
What is the net insider flow at KOD over the last 6 months?
Over the trailing 180 days, insiders at KOD have net bought $177.6M based on SEC Form 4 disclosures.
What was the largest insider purchase at KOD?
The largest single insider open-market purchase at KOD in the rolling window was $154.1M by Director, 10% Owner BAKER BROS. ADVISORS LP on 2026-09-28.
What is the total insider buy and sell value at KOD in the current window?
Inside the rolling window, insiders at KOD bought $241.3M and sold $4.9M based on SEC Form 4 filings.
Can I get alerts for KOD insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Kodiak Sciences Inc. (KOD). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Kodiak Sciences Inc. is in the Healthcare sector.